Global Cardiovascular Surgical Devices Market Size study & Forecast, by Type (Interventional Cardiac Surgery, Cardiac Rhythm Management, Traditional Cardiac Surgery, Others), by Technology (Perfusion Disposables, Cardiopulmonary Bypass Equipment, Beating

Global Cardiovascular Surgical Devices Market Size study & Forecast, by Type (Interventional Cardiac Surgery, Cardiac Rhythm Management, Traditional Cardiac Surgery, Others), by Technology (Perfusion Disposables, Cardiopulmonary Bypass Equipment, Beating Heart Surgery Treatment, Ventricular Assist Device, Cardiac Ablation Devices, Others) and Regional Analysis, 2023-2030

Global Cardiovascular Surgical Devices Market is valued at approximately USD XXX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. Cardiovascular surgical devices are medical instruments and tools used in surgical procedures involving the cardiovascular system, which includes the heart and blood vessels. These devices are designed to assist surgeons in diagnosing and treating various cardiovascular conditions and diseases. The market for cardiovascular surgical devices is anticipated to be driven by the increase in vascular problems and congenital anomalies among the elderly population. Globally, the prevalence of cardiovascular disorders is increasing as a result of ageing populations, poor nutrition, and rising obesity rates, all of which are predicted to boost the demand for cardiovascular procedures. Also, growing prevalence of chronic heart diseases and increasing availability of efficient devices are anticipated to support the market growth during the forecast period.

Moreover, the growing prevalence of cardiovascular disorders, along with advancements in surgical techniques, an aging population, rising healthcare expenditure, and increased awareness, collectively contribute to the growth of the Cardiovascular Surgical Devices Market. The demand for these devices is expected to continue to rise as the burden of cardiovascular diseases persists. According to the American Heart Association, cardiovascular diseases are projected around 17.3 million deaths globally every year. And the cases are estimated to rise about 23.6 million by 2030.
Additionally, rising technological advancement in devices and growing research and development activities related to cardiovascular surgical devices are anticipated to create lucrative opportunities for the market during forecast period. However, the stringent and longer approval processes by the regulatory authorities stifle market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Cardiovascular Surgical Devices Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the presence of key market players, growing prevalence of heart diseases in the U.S. and Canada, rising technological advancement and growing product innovation and development in the region. Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising geriatric population, growing prevalence of chronic heart diseases, rising public-private investments in healthcare sector, and cohesive government initiatives are anticipated to support the market growth during forecast period.

Major market players included in this report are:
Medtronic Inc
Maquet GmbH & Co. KG
Sorin Group
Terumo Corp
C.R. Bard Inc
SEMMT Inc
St. Jude Medical
Medwaves Incorporated
Edward Lifesciences
EndoPhotonix Inc.

Recent Developments in the Market:
 In July 2021, Angel Medical Systems, Inc. started the first commercial implantation of their flagship product, “The Guardian” device in the U.S. region.

Global Cardiovascular Surgical Devices Market Report Scope:
 Historical Data – 2020 - 2021
 Base Year for Estimation – 2022
 Forecast period - 2023-2030
 Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
 Segments Covered - Type, Technology, Region
 Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa


The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:
Interventional Cardiac Surgery
Cardiac Rhythm Management
Traditional Cardiac Surgery
Others
By Technology:
Perfusion Disposables
Cardiopulmonary Bypass Equipment
Beating Heart Surgery Treatment
Ventricular Assist Device
Cardiac Ablation Devices
Others

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Companies Mentioned
Medtronic Inc
Maquet GmbH & Co. KG
Sorin Group
Terumo Corp
C.R. Bard Inc
SEMMT Inc
St. Jude Medical
Medwaves Incorporated
Edward Lifesciences
EndoPhotonix Inc.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.